ReviewCarcinogenesis2026
Climate change, the exposome, and early-onset carcinogenesis.
Review in Carcinogenesis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The modern exposome in early-onset carcinogenesis.Carcinogenesis · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The incidence of early-onset cancers (diagnosis before 50 years of age) has been steadily increasing globally, presenting a significant public health challenge. While genetic predispositions play a role, most cancers cannot be traced to heritable components. Furthermore, the rapid rise in the incidence rates of these cancers strongly suggests the influence of environmental factors that constitute the "exposome." This perspective article integrates recent findings linking climate change and broader planetary health challenges to pervasive inflammation in the development of chronic diseases, especially cancer. We propose that the complex interplay of anthropogenic climate change, biodiversity loss, environmental degradation, disruption of ecological systems, exposure to environmental pathogens and toxins, industrialized food systems, and consumption of suboptimal, proinflammatory diets containing high concentrations of ultra-processed foods, creates a procarcinogenic exposome that may be particularly important during critical developmental windows, leading to increased susceptibility to carcinogenesis relatively early in life. Framed through a planetary health perspective, this article synthesizes evidence on how large-scale ecological disruption alters the human exposome and contributes to chronic inflammation, metabolic dysregulation, immune dysfunction, and cellular damage, all recognized drivers of cancer development. Although our primary focus is on early-onset cancers, many of these mechanisms are relevant across the cancer continuum and may influence carcinogenesis throughout the life course. We highlight the need for transdisciplinary research and integrated solutions that address both individual behaviors and systemic environmental and policy changes to mitigate the growing burden of early-onset cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.